CCL2 and neoplasm: High-expression PIPKIγ stimulates the AKT-mTOR signaling activation, leading to increased STAT3 phosphorylation and ultimately promoting CCL2 expression which further facilitates macrophage infiltration and suppresses the activation of CRC tumor immune response (89).